Intimation for Schedule of Analysts / Investor Conference

July 22, 2026 To, To, Listing Operation Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (East), Mumbai- 400051 (Scrip Code: 544644) (SYMBOL: CORONA) Dear Sir / Madam, Sub.: Intimation of Schedule of Analyst / Investor Call Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Company will hold its Q1 FY27 earnings conference call (i.e. post earnings / quarterly call) on Monday, August 03, 2026 at 11:30 a.m. (IST) to discuss the financial results of the Company for the first quarter and three months ended June 30, 2026 as per details enclosed herewith. This intimation is also being made available on the website of the Company at www.coronaremedies.com You are requested to take note of the above. Thanking you. Your faithfully, For CORONA Remedies Limited Chetna Dharajiya Company Secretary and Compliance Officer Encl.: A/a CONCALL INVITE 360 ONE CM Research shall hold a Conference Call of CORONA Remedies Limited to discuss the 1QFY27 Results on Monday, 03rd August 2026 at 11:30 Hrs IST The Management Team will be represented by: Mr. Nirav Mehta – Managing Director & CEO Mr. Ankur Mehta - Joint Managing Director Mr. Bhavin Bhagat - Chief Financial Officer You are cordially invited Diamond Pass Link https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0782677&linkS ecurityString=6ad28d1a1 Universal Dial-in Numbers +91 22 6280 1222 / +91 22 7115 8123 International Toll Free: Argentina: 0080014243444 | Australia: 0080014243444 | Belgium: 0080014243444 | Canada: 01180014243444 China: 4008428405 | France: 0800914745 | Germany: 0080014243444 | Hong Kong: 800964448 Italy: 0080014243444 | Japan: 00531161110 | Netherlands: 08000229808 | Poland: 008001124248 Singapore: 8001012045 | South Korea: 00180014243444 | Sweden: 0080014243444 Thailand: 00180014243444 | UK: 08081011573 | USA: 18667462133 For further information, please contact Mr. Rohit Bhat / Mr. Maulik Varia 360 ONE Capital Market Research +91 22 4031 7150 / +91-22-4031 7275 rohit.bhat@360.one / maulik.varia@360.one